Amgen Non-GAAP EPS of $5.29 beats by $0.53, revenue of $9.9B beats by $440M

amgen-non-gaap-eps-of-$529-beats-by-$053,-revenue-of-$9.9b-beats-by-$440m
  • Amgen press release (AMGN): Q4 Non-GAAP EPS of $5.29 beats by $0.53.
  • Revenue of $9.9B (+8.8% Y/Y) beats by $440M.

  • EPS Guidance for the Year Ending December 31, 2026

    (Unaudited)
     

    GAAP diluted EPS guidance

    		  

    $ 15.45

    		  

    —

    		  

    $ 16.94

    Known adjustments to arrive at non-GAAP*:

    		            

    Acquisition-related expenses (a)

    		  

    6.06

    		  

    —

    		  

    6.15

    Non-GAAP diluted EPS guidance

    		  

    $ 21.60

    		  

    —

    		  

    $ 23.00